Bioetch Stocks

Analysts at BTIG laid out the bullish case for owning shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) — a "storied" company with a strong growth outlook. BTIG's Dane Leone initiates coverage of Vertex's stock with a Buy and $200 price target, on the thesis that...